SEATTLE–(BUSINESS WIRE)–Milliman CareFlowIQ™, transforming fragmented healthcare data into trusted, proven, evidence-based insights for informed decision-makingSEATTLE–(BUSINESS WIRE)–Milliman CareFlowIQ™, transforming fragmented healthcare data into trusted, proven, evidence-based insights for informed decision-making

Heuro Health chooses Milliman CareFlowIQ’s real-time clinical intelligence to advance obesity care

2026/01/08 03:32
4분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

SEATTLE–(BUSINESS WIRE)–Milliman CareFlowIQ™, transforming fragmented healthcare data into trusted, proven, evidence-based insights for informed decision-making, today announced a new client relationship with Heuro Health, a fast-growing obesity and metabolic health provider integrating GLP-1 medications with physician-led, dietitian-supported, and neuroplasticity-based coaching. Through this collaboration, Heuro Health will incorporate Milliman CareFlowIQ’s risk stratification and real-time clinical insights directly into its obesity care platform, strengthening personalized care delivery and enhancing measurable outcomes for members and employers.

By leveraging Milliman CareFlowIQ’s proven clinical intelligence platform, Heuro Health will be able to segment patient populations into medical cohorts to enable customized care. Milliman CareFlowIQ continuously tracks their progress across key biometric and clinical markers, including HbA1c, weight loss trajectories, medication adherence, and comorbidity improvement, to deliver timely, individualized interventions.

“Combining Heuro Health’s science-driven care model with Milliman CareFlowIQ’s clinical intelligence represents a major step forward in personalized, accountable obesity medicine,” said Ben Newton, CEO of Milliman CareFlowIQ. “Using CareFlowIQ, Heuro can identify at-risk populations and monitor progress metric by metric, turning fragmented clinical data into actionable intelligence that improves care delivery and supports long-term metabolic success.”

“I am pleased to be working with Milliman CareFlowIQ. Milliman’s ability to segment patients into the right clinical cohorts allows Heuro to tailor treatment options and medication intensity based on obesity class. This helps employers offer world-class obesity care while keeping treatment aligned with predictable cost models. Together, Heuro and Milliman can monitor patient progress in real time, allowing physicians to adjust care protocols when needed while also demonstrating measurable financial benefits for employers through reduced claims. We expect this partnership with Milliman to take our already impressive results to the next level,” said Jesse Kessler, CEO of Heuro Health. “Using CareFlowIQ, we are bringing precision and accountability to obesity medicine, helping every patient achieve meaningful and measurable change.”

About Heuro Health

Heuro Health is a science-driven obesity and metabolic health company delivering personalized, clinically guided weight loss care. Built on the foundation that effective obesity treatment requires both medical expertise and behavior change science, Heuro combines board-certified obesity specialists, registered dietitians, and evidence-based coaching with weight loss medications. Heuro’s tailored care pathways adjust treatment duration, medication intensity, and support based on each patient’s obesity class and clinical profile. Heuro Health is committed to delivering obesity care that is grounded in science, powered by data, and delivered with empathy, helping individuals achieve meaningful, lasting health improvement.

About Milliman CareFlowIQ

Milliman CareFlowIQ, developed by the experts at Milliman Pluritem, is the superior, scalable clinical data platform that delivers clinical intelligence to healthcare’s data chaos. Through a next-generation clinical data pipeline, CareFlowIQ transforms legacy formats and disconnected records into searchable, clean and context-rich insights. CareFlowIQ enables healthcare providers and health tech leadership to accelerate onboarding, identify care gaps, and make confident, data-driven decisions. Built to handle real world complexity, CareFlowIQ extracts meaningful narratives from PDFs, even doctor’s notes, to unlock relevant clinical insights in seconds, and support API integration or direct clinician use. It’s not just more clinical data—it’s clinical intelligence built around the complete patient story. Visit us at CareFlowIQ.com.

About Milliman

Milliman leverages deep expertise, actuarial rigor, and advanced technology to develop solutions for a world at risk. We help clients in the public and private sectors navigate urgent, complex challenges, from extreme weather and market volatility to financial insecurity and rising health costs—so they can meet their business, financial, and social objectives. Our solutions encompass insurance, financial services, healthcare, life sciences, and employee benefits. Founded in 1947, Milliman is an independent firm with offices in major cities around the globe. Visit us at milliman.com.

Contacts

Jeremy Engdahl-Johnson

Milliman, Inc.

Tel: +1 646.473.3021

Jeremy.engdahl-johnson@milliman.com

시장 기회
RealLink 로고
RealLink 가격(REAL)
$0.0653
$0.0653$0.0653
+0.97%
USD
RealLink (REAL) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!